Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Berlin - Delayed Quote EUR

Novo Nordisk A/S (NOV.BE)

54.14
-1.15
(-2.08%)
At close: April 25 at 4:52:07 PM GMT+2
Loading Chart for NOV.BE
  • Previous Close 55.29
  • Open 55.44
  • Bid --
  • Ask --
  • Day's Range 54.14 - 55.44
  • 52 Week Range 50.95 - 139.58
  • Volume 5
  • Avg. Volume 407
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date May 7, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: NOV.BE

View More

Performance Overview: NOV.BE

Trailing total returns as of 4/25/2025, which may include dividends or other distributions. Benchmark is OMX Copenhagen 25 Index (^OMXC25) .

YTD Return

NOV.BE
26.26%
OMX Copenhagen 25 Index (^OMXC25)
11.30%

1-Year Return

NOV.BE
45.01%
OMX Copenhagen 25 Index (^OMXC25)
16.99%

3-Year Return

NOV.BE
49.40%
OMX Copenhagen 25 Index (^OMXC25)
10.13%

5-Year Return

NOV.BE
243.26%
OMX Copenhagen 25 Index (^OMXC25)
29.70%

Compare To: NOV.BE

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: NOV.BE

View More

Valuation Measures

Annual
As of 4/25/2025
  • Market Cap

    239.90B

  • Enterprise Value

    250.15B

  • Trailing P/E

    17.86

  • Forward P/E

    14.77

  • PEG Ratio (5yr expected)

    0.91

  • Price/Sales (ttm)

    6.21

  • Price/Book (mrq)

    12.51

  • Enterprise Value/Revenue

    6.43

  • Enterprise Value/EBITDA

    13.60

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: NOV.BE

View More

Company Insights: NOV.BE

Research Reports: NOV.BE

View More